ATE92335T1 - Reinigung von keuchhustenantigenen. - Google Patents
Reinigung von keuchhustenantigenen.Info
- Publication number
- ATE92335T1 ATE92335T1 AT87300387T AT87300387T ATE92335T1 AT E92335 T1 ATE92335 T1 AT E92335T1 AT 87300387 T AT87300387 T AT 87300387T AT 87300387 T AT87300387 T AT 87300387T AT E92335 T1 ATE92335 T1 AT E92335T1
- Authority
- AT
- Austria
- Prior art keywords
- lpf
- produced
- fha
- purification
- fimbrial
- Prior art date
Links
- 201000005702 Pertussis Diseases 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
- 108010081690 Pertussis Toxin Proteins 0.000 abstract 4
- 239000012134 supernatant fraction Substances 0.000 abstract 3
- 230000001413 cellular effect Effects 0.000 abstract 2
- 241000588832 Bordetella pertussis Species 0.000 abstract 1
- 238000009630 liquid culture Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868601279A GB8601279D0 (en) | 1986-01-20 | 1986-01-20 | Purification of pertussis antigens |
| EP87300387A EP0231083B1 (de) | 1986-01-20 | 1987-01-16 | Reinigung von Keuchhustenantigenen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE92335T1 true ATE92335T1 (de) | 1993-08-15 |
Family
ID=10591636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87300387T ATE92335T1 (de) | 1986-01-20 | 1987-01-16 | Reinigung von keuchhustenantigenen. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4784589A (de) |
| EP (1) | EP0231083B1 (de) |
| JP (1) | JP2538224B2 (de) |
| KR (1) | KR950010323B1 (de) |
| CN (1) | CN1028206C (de) |
| AT (1) | ATE92335T1 (de) |
| AU (1) | AU592727B2 (de) |
| CA (1) | CA1280693C (de) |
| DE (1) | DE3786806T2 (de) |
| DK (1) | DK172936B1 (de) |
| GB (1) | GB8601279D0 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1337859C (en) * | 1987-04-24 | 1996-01-02 | Masashi Chazono | Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine |
| GB8807860D0 (en) * | 1988-04-05 | 1988-05-05 | Connaught Lab | Pertussis vaccine |
| CA1341123C (en) * | 1988-10-27 | 2000-10-17 | David A. Relman | Filamentous hemagglutinin of b. pertussis |
| JP2706792B2 (ja) * | 1988-11-29 | 1998-01-28 | 財団法人化学及血清療法研究所 | 百日咳毒素のトキソイド化法 |
| GB8910570D0 (en) * | 1989-05-08 | 1989-06-21 | Wellcome Found | Acellular vaccine |
| US5391715A (en) * | 1989-11-06 | 1995-02-21 | Smithkline Beecham Biologicals | Method for isolating and purifying bordetella pertussis antigenic factors |
| DE69025375T2 (de) | 1989-11-06 | 1996-08-01 | Smithkline Beecham Biolog | Verfahren |
| DK0515415T3 (da) * | 1990-02-12 | 1995-11-27 | Smithkline Beecham Biolog | Hidtil ukendt vaccine og fremgangsmåde til fremstilling deraf |
| EP0484621A3 (en) * | 1990-07-11 | 1992-08-26 | American Cyanamid Company | Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens |
| US5445817A (en) * | 1992-08-21 | 1995-08-29 | The United States Of America As Represented By The Department Of Health And Human Services | Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines |
| AU2352595A (en) * | 1994-04-28 | 1995-11-29 | Takeda Chemical Industries Ltd. | Method of separating protective components of bordetella pertussis |
| CA2433502A1 (en) * | 1995-05-04 | 1996-11-07 | Aventis Pasteur Limited | Acellular pertussis vaccines and methods of preparation thereof |
| US7091311B2 (en) * | 1996-06-07 | 2006-08-15 | Smithkline Beecham Corporation | Peptides and compounds that bind to a receptor |
| MXPA05003057A (es) | 2002-09-18 | 2006-04-18 | Johnson & Johnson | Metodos para aumentar la produccion de celulas madre hematopoyeticas y plaquetas. |
| EP2863943B1 (de) | 2013-03-08 | 2016-07-13 | Crucell Holland B.V. | Nicht zellulärer pertussis-impfstoff |
| CN110358802B (zh) * | 2019-08-16 | 2021-06-18 | 长春百克生物科技股份公司 | 一种去除百日咳组分菌毛蛋白2/3内毒素的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4247452A (en) * | 1978-03-01 | 1981-01-27 | The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland | Purification of pertussis haemagglutinins |
| JPS5750925A (en) * | 1980-09-12 | 1982-03-25 | Takeda Chem Ind Ltd | Preparation of pertussis toxoid |
| US4474758A (en) * | 1981-11-19 | 1984-10-02 | American Cyanamid Company | Haemophilus influenzae type b and pertussis outer membrane component combined vaccine |
| HU188847B (en) * | 1983-02-22 | 1986-05-28 | Human Oltoanyagtermeloe Es Kutato Intezet,Hu | Process for producing liophylized combined vaccines |
| CA1213234A (en) * | 1983-03-30 | 1986-10-28 | Akihiro Ginnaga | Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine |
| US4551429A (en) * | 1983-09-15 | 1985-11-05 | American Home Products Corporation | Stimulation of antigen production by Bordetella pertussis |
| JPS6098988A (ja) * | 1983-11-01 | 1985-06-01 | Chemo Sero Therapeut Res Inst | Lpf−haの精製法 |
| AU571078B2 (en) * | 1984-04-14 | 1988-03-31 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Purification of filamentous hemagglutinin |
-
1986
- 1986-01-20 GB GB868601279A patent/GB8601279D0/en active Pending
-
1987
- 1987-01-16 EP EP87300387A patent/EP0231083B1/de not_active Expired - Lifetime
- 1987-01-16 AT AT87300387T patent/ATE92335T1/de not_active IP Right Cessation
- 1987-01-16 DE DE87300387T patent/DE3786806T2/de not_active Expired - Lifetime
- 1987-01-19 KR KR1019870000366A patent/KR950010323B1/ko not_active Expired - Lifetime
- 1987-01-19 DK DK198700272A patent/DK172936B1/da not_active IP Right Cessation
- 1987-01-19 CA CA000527592A patent/CA1280693C/en not_active Expired - Lifetime
- 1987-01-19 AU AU67664/87A patent/AU592727B2/en not_active Expired
- 1987-01-20 US US07/008,880 patent/US4784589A/en not_active Expired - Lifetime
- 1987-01-20 CN CN87100399A patent/CN1028206C/zh not_active Expired - Lifetime
- 1987-01-20 JP JP62009178A patent/JP2538224B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK27287D0 (da) | 1987-01-19 |
| KR870006902A (ko) | 1987-08-13 |
| EP0231083A3 (en) | 1988-06-08 |
| JP2538224B2 (ja) | 1996-09-25 |
| US4784589A (en) | 1988-11-15 |
| EP0231083B1 (de) | 1993-08-04 |
| DE3786806D1 (de) | 1993-09-09 |
| AU6766487A (en) | 1987-07-23 |
| CA1280693C (en) | 1991-02-26 |
| GB8601279D0 (en) | 1986-02-26 |
| DE3786806T2 (de) | 1993-12-09 |
| CN87100399A (zh) | 1987-09-09 |
| EP0231083A2 (de) | 1987-08-05 |
| JPS62234031A (ja) | 1987-10-14 |
| AU592727B2 (en) | 1990-01-18 |
| DK27287A (da) | 1987-07-21 |
| DK172936B1 (da) | 1999-10-11 |
| CN1028206C (zh) | 1995-04-19 |
| KR950010323B1 (ko) | 1995-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE92335T1 (de) | Reinigung von keuchhustenantigenen. | |
| MX9708481A (es) | Vacunas acelulares de pertussis y metodos de preparacion de las mismas. | |
| DK496485D0 (da) | Transformation af gaer-stammer af slaegten pichia | |
| ATE180477T1 (de) | Verfahren und zubereitungen zur isolierung von taxanen | |
| DK0522291T3 (da) | Fremgangsmåde til rensning af hepatitis A-virus (HAV), således renset virus og vaccinepræparater indeholdende dette | |
| ATE107535T1 (de) | Gaschromatographische methode zur trennung von wasserstoffisotopen. | |
| DE761230T1 (de) | Aus Bordetella pertussis Aussenmembranprotein enthaltender Impfstoffe und Verfahren zu seiner Herstellung | |
| SE8402861D0 (sv) | Rening av biologiskt material | |
| ATE97448T1 (de) | Verfahren zur isolierung von ca 125-antigen. | |
| DE69222150D1 (de) | Prozess zur produktion von cyclosporin-a und/oder c | |
| ZA908801B (en) | Process for purifying antigenic factors from b.pertussis | |
| AT384032B (de) | Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag) | |
| EP0158317A3 (en) | Biologic and method of preparing same | |
| DK0408742T3 (da) | Fremgangsmåde til fremstilling og rensning af hepatitis B vaccine | |
| ATE2339T1 (de) | Verfahren zur herstellung von sphingomyelinase, sphingomyelinase und deren verwendung. | |
| JPS5464683A (en) | Preparation of unicellular protein | |
| JPS5675095A (en) | Preparation of heat-resistant acetic acid kinase | |
| JPS5750892A (en) | Microbial preparation of valeric acid derivative | |
| DK222887D0 (da) | Fremgangsmaade til fremstilling af l-aminosyrer ved fermentering af alfa-ketocarboxylsyrer | |
| DE3750330D1 (de) | Verfahren zur Herstellung eines Impfstoffs gegen Hepatitis B. | |
| JPS5539730A (en) | Preparation of ubiquinone q10 | |
| FI881294A0 (fi) | FSME-viruksen läntisen alatyypin eristettyjä DNA- ja RNA-molekyylejä, näitä sisältäviä vektoreita ja soluviljelmiä sekä menetelmä näiden koodittamien peptidien valmistamiseksi | |
| TH20014A (th) | วิธีการแยกส่วนประกอบป้องกันโรคไอกรนของ Bordetella pertussis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |